Allergy therapy: the therapeutic potential of targeting sphingosine kinase signalling in mast cells.
D000707:Anaphylaxis / Q000209:etiology; D001249:Asthma / Q000209:etiology / Q000628:therapy; D004791:Enzyme Inhibitors / Q000627:therapeutic use; D006801:Humans; D006967:Hypersensitivity / Q000209:etiology / Q000628:therapy*; D008407:Mast Cells / Q000502:physiology*; D017853:Phosphotransferases (Alcohol Group Acceptor) / Q000037:antagonists & inhibitors / Q000502:physiology*; D015398:Signal Transduction / Q000502:physiology*; D000099157:Sphingosine Kinase
D004791:Enzyme Inhibitors; D017853:Phosphotransferases (Alcohol Group Acceptor); D000099157:Sphingosine Kinase